F-group (family)
375.1.1.5 Ribosomal_L44
Ligands and drugs
847
Member domains
569
with ligand contacts (≤ 4 Å)
67.2% of members
355
with DrugDomain annotations
41.9% of members
9
with a DrugBank compound
1.1% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 375.1.1.5 belongs to X-group 375 Rubredoxin-like, which binds 5.1 ligand superclasses per 20 proteins, narrower than 81% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00127 | SPM | Spermine | 3 |
| DB03566 | SPD | Spermidine | 3 |
| DB00131 | A | Adenosine phosphate | 2 |
| DB03403 | C | Cytidine-5'-Monophosphate | 2 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| ZNmetal | ZINC ION | 489 |
| MGmetal | MAGNESIUM ION | 208 |
| OHX | osmium (III) hexammine | 69 |
| CDmetal | CADMIUM ION | 67 |
| CL | CHLORIDE ION | 67 |
| NAmetal | SODIUM ION | 53 |
| SRmetal | STRONTIUM ION | 30 |
| 3HE | 4-{(2R)-2-[(1S,3S,5S)-3,5-dimethyl-2-oxocyclohexyl]-2-hydroxyethyl}piperidine-2,6-dione | 28 |
| Kmetal | POTASSIUM ION | 23 |
| 3K5 | 3-O-acetyl-2-O-(3-O-acetyl-6-deoxy-beta-D-glucopyranosyl)-6-deoxy-1-O-{[(2R,2'S,3a'R,4''S,5''R,6'S,7a'S)-5''-methyl-4''-{[(2E)-3-phenylprop-2-enoyl]oxy}decahydrodispiro[oxirane-2,3'-[1]benzofuran-2',2''-pyran]-6'-yl]carbonyl}-beta-D-glucopyranose | 18 |
| SPM | SPERMINE | 14 |
| ATP | ADENOSINE-5'-TRIPHOSPHATE | 11 |
| UNX | UNKNOWN ATOM OR ION | 10 |
| 3H3 | 4-{(2R,5S,6E)-2-hydroxy-5-methyl-7-[(2R,3S,4E,6Z,10E)-3-methyl-12-oxooxacyclododeca-4,6,10-trien-2-yl]-4-oxooct-6-en-1-yl}piperidine-2,6-dione | 7 |
| T1C | TIGECYCLINE | 3 |
| 7AL | Chlorolissoclimide | 2 |
| G5B | (3~{R})-3-[(1~{S})-2-[(1~{S},4~{a}~{R},6~{S},7~{S},8~{a}~{R})-6,7-bis(chloranyl)-5,5,8~{a}-trimethyl-2-methylidene-3,4,4~{a},6,7,8-hexahydro-1~{H}-naphthalen-1-yl]-1-oxidanyl-ethyl]pyrrolidine-2,5-dione | 2 |
| VDU | fluorolissoclimide | 2 |
| X1K | (3~{R})-3-[(1~{S})-2-[(1~{R},3~{S},4~{a}~{S},8~{a}~{S})-5,5,8~{a}-trimethyl-2-methylidene-3-oxidanyl-3,4,4~{a},6,7,8-hexahydro-1~{H}-naphthalen-1-yl]-1-oxidanyl-ethyl]pyrrolidine-2,5-dione | 2 |
| XBI | (3~{R})-3-[(1~{S})-2-[(1~{R},3~{S},4~{a}~{S},7~{S},8~{a}~{S})-5,5,7,8~{a}-tetramethyl-2-methylidene-3-oxidanyl-3,4,4~{a},6,7,8-hexahydro-1~{H}-naphthalen-1-yl]-1-oxidanyl-ethyl]pyrrolidine-2,5-dione | 2 |